Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-12

Clinical Trial Update: Survival of Patients With Primary Prophylactic ICD Indication [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports survival outcomes for patients with a primary prophylactic ICD indication. The study was sponsored by Biotronik SE & Co. KG an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biotronik ICD System

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Primary Prevention, Tachycardia, Ventricular | Phase 4 | Status: COMPLETED